BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
Atrial fibrillation clinical trials and catalysts
Active industry-sponsored trials on ClinicalTrials.gov for atrial fibrillation: 160 (67 sponsors; 28 newly posted in the last 180 days, 6 stopped in the last 180 days; 9 new-entrant sponsors). Momentum score 9.1, rank 77 of 91 on the disease-area ranking. As of 2026-11-18.
Phase distribution: Early Phase 1 0, Phase 1 1, Phase 2 11, Phase 3 5, Phase 4 1, N/A 142.
Most active sponsors, by phase
| Sponsor | Active trials | By phase | New (window) | Upcoming readouts |
|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN | 3 | P3 2, P2 1 | 1 | 1 |
| Anthos Therapeutics, Inc. | 2 | P2 1, P3 1 | 0 | 0 |
| Novartis Pharmaceuticals NVS | 2 | P3 1, P2 1 | 1 | 0 |
| Janssen Research & Development, LLC | 1 | P3 1 | 0 | 1 |
| Boston Scientific Corporation BSX | 20 | NA 20 | 2 | 5 |
| Medtronic Cardiac Ablation Solutions MDT | 11 | NA 11 | 1 | 2 |
| Biosense Webster, Inc. | 10 | NA 10 | 2 | 4 |
| Abbott Medical Devices | 9 | NA 9 | 0 | 2 |
| Shanghai MicroPort EP MedTech Co., Ltd. | 6 | NA 6 | 1 | 0 |
| Asklepios proresearch | 5 | NA 5 | 1 | 1 |
| Kardium Inc. | 5 | NA 5 | 2 | 1 |
| LUMA Vision Ltd. | 5 | NA 5 | 1 | 2 |
| Volta Medical | 5 | NA 5 | 2 | 1 |
| AtriCure, Inc. ATRC | 4 | NA 4 | 0 | 2 |
| CardioFocus | 4 | NA 4 | 1 | 1 |
| Pulse Biosciences, Inc. PLSE | 4 | NA 4 | 0 | 2 |
| CathVision ApS | 3 | NA 3 | 0 | 2 |
| Hangzhou Dinova EP Technology Co., Ltd | 3 | NA 3 | 0 | 0 |
| HUINNO Co., Ltd | 3 | NA 3 | 2 | 2 |
| Append Medical Ltd. | 2 | NA 2 | 1 | 0 |
| Biotronik SE & Co. KG | 2 | NA 2 | 0 | 0 |
| Conformal Medical, Inc | 2 | NA 2 | 0 | 0 |
| Javelin Medical | 2 | NA 2 | 0 | 0 |
| Lifetech Scientific (Shenzhen) Co., Ltd. | 2 | NA 2 | 0 | 0 |
| Peerbridge Health, Inc | 2 | NA 2 | 1 | 0 |
Recently stopped trials
- NCT05653583 Cala Health, Inc. - terminated: The Sponsor and Principal Investigator have mutually agreed to initiate study closure due to prolonged recruitment challenges that have prev Peripheral Nerve Stimulation Therapy for Atrial Fibrillation
- NCT06168942 Jaguar LAA, Inc. - suspended: Potential unwrapping of the LAA post implant with clinically significant leaks. A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
- NCT05147792 Conformal Medical, Inc - suspended: Enrollment has been temporarily suspended out of an abundance of caution and in close consultation with trial leadership and regulatory bodi The CONFORM Pivotal Trial
- NCT02928497 Boston Scientific Corporation - terminated: The enrollment was prematurely terminated on October 15, 2020, with 481 randomized patients. As discussed in the ASAP-TOO Update Meeting hel Assessment of the WATCHMANâ„¢ Device in Patients Unsuitable for Oral Anticoagulation
- NCT06189365 Abbott Medical Devices - terminated: This study was terminated due to the shift in Sponsor's business strategy. Amplatzer Amulet China Post Market Study (PMS)
- NCT05230524 Medtronic Cardiac Ablation Solutions - terminated: Sponsor and FDA agreed on early termination. Results will be posted by the FDA on the FDA Post-Approval Studies (PAS) Database- https://www. DIAMOND AF Post-Approval Study
Upcoming trial readouts (next 90 days)
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-12-08 est. | P3 | Janssen Research & Development, LLC | NCT05757869 A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | Atrial Fibrillation | active not recruiting | 20284 |
| 2027-02-09 est. | P2 | Regeneron Pharmaceuticals REGN | NCT07175428 Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation | Atrial Fibrillation (AF) | recruiting | 1200 |
Readouts in the last 180 days
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| None found. | ||||||
Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "atrial fibrillation"); readouts matched by condition text. Registry counts only; not a forecast.
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.